Select a medication above to begin.
Ebvallo
tabelecleucel
Adult Dosing .
Dosage forms: INJ
Investigational New Drug (IND)
- [FDA approval denied, January 2026]
post-transplant lymphoproliferative disease, Epstein-Barr virus positive
- [FDA approval denied]
- Info: EBV-specific T-cell immunotherapy, targets and eliminates EBV-infected cells
Peds Dosing .
- Dosage forms: INJ
Investigational New Drug (IND)
- [FDA approval denied, January 2026]
post-transplant lymphoproliferative disease, Epstein-Barr virus positive
- [FDA approval denied]
- Info: EBV-specific T-cell immunotherapy, targets and eliminates EBV-infected cells